查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1619216

血液檢測市場規模、佔有率、成長分析，按類型、方法、最終用戶、地區分類 - 產業預測，2024-2031 年

Blood Testing Market Size, Share, Growth Analysis, By Type (Glucose Testing, Lipid Panel Testing), By Methods (Manual Blood Testing, Automated Blood Testing), By End User, By Region - Industry Forecast 2024-2031
出版日期: | 出版商: SkyQuest | 英文 157 Pages | 商品交期: 3-5個工作天內

價格
簡介目錄

2022年全球血液檢測市場規模估值為956.5億美元，從2023年的1034.9億美元成長到2031年的1944.2億美元，預計在預測期內（2024-2031年）將成長。為8.2%）。

由於政府和私營部門醫療保健支出的增加，預計全球血液檢測市場將顯著成長。跨國醫療機構積極開發創新技術並提高人們對慢性病的認知，進一步推動血液檢測的需求。慢性病（尤其是糖尿病）的增加預計到 2031 年將影響 7.83 億成年人，這對健康評估產品產生了巨大的需求。 CMS 和 FDA 等監管機構對於推廣符合 CLIA 的診斷測試至關重要，以加強疾病的早期發現。監管支持的激增和對健康問題的日益關注，為血液檢測領域的企業提供了利潤豐厚的機會，並為未來幾年的市場強勁擴張奠定了基礎。

目錄

介紹

  • 研究目的
  • 調查範圍
  • 定義

調查方法

  • 資訊採購
  • 二手資料和主要資料方法
  • 市場規模預測
  • 市場假設與限制

執行摘要

  • 全球市場展望
  • 供需趨勢分析
  • 按細分市場的機會分析

市場動態及展望

  • 市場概況
  • 市場規模
  • 市場動態
    • 促進因素和機遇
    • 抑制因素和挑戰
  • 波特的分析

主要市場考察

  • 關鍵成功因素
  • 競爭程度
  • 主要投資機會
  • 市場生態系統
  • 市場吸引力指數（2023）
  • PESTEL分析
  • 總體經濟指標
  • 價值鏈分析
  • 價格分析
  • 技術進步
  • 監管環境
  • 案例研究
  • 專利分析

血液檢測市場規模：按類型和複合年成長率（2024-2031）

  • 市場概況
  • 血糖測試
  • 血脂檢查
  • 前列腺特異性抗原（PSA）測試
  • 血中尿素氮（BUN）測試
  • 甲狀腺刺激素測試
  • 其他類型
    • 直接低密度脂蛋白測試
    • 睪酮測試

血液檢測市場規模：依方法及複合年成長率（2024-2031）

  • 市場概況
  • 手動驗血
  • 自動驗血

血液檢測市場規模：依最終用戶和複合年成長率（2024-2031）

  • 市場概況
  • 診斷實驗室
  • 醫院
  • 其他最終用戶

血液檢測市場規模：按地區及複合年成長率（2024-2031）

  • 北美洲
    • 美國
    • 加拿大
  • 歐洲
    • 德國
    • 西班牙
    • 法國
    • 英國
    • 義大利
    • 其他歐洲國家地區
  • 亞太地區
    • 中國
    • 印度
    • 日本
    • 韓國
    • 其他亞太地區
  • 拉丁美洲
    • 巴西
    • 其他拉丁美洲地區
  • 中東/非洲
    • 海灣合作理事會國家
    • 南非
    • 其他中東/非洲

競爭資訊

  • 前5名企業對比
  • 主要企業市場定位（2023年）
  • 主要市場參與者所採取的策略
  • 近期市場趨勢
  • 公司市場佔有率分析（2023）
  • 主要企業簡介
    • 公司簡介
    • 產品系列分析
    • 按細分市場分類的佔有率分析
    • 收益與前一年同期比較（2021-2023）

主要企業簡介

  • Abbott
  • F. Hoffmann-La Roche Ltd
  • Bio-Rad Laboratories, Inc.
  • bioMerieux
  • Quest Diagnostics Incorporated
  • Biomerica
  • BD
  • Siemens Healthineers AG
  • Danaher Corporation
  • Trinity Biotech Plc
  • Thermo Fisher Scientific
  • Sysmex Corporation
  • Dr Lal PathLabs Limited
  • Alere Inc.
  • Cepheid Corporation

結論和建議

簡介目錄
Product Code: SQMIG35A2519

Global Blood Testing Market size was valued at USD 95.65 billion in 2022 and is poised to grow from USD 103.49 billion in 2023 to USD 194.42 billion by 2031, growing at a CAGR of 8.2% during the forecast period (2024-2031).

The global blood testing market is projected to experience significant growth, fueled by increasing medical expenditures from both government and private sectors. Multinational healthcare organizations are actively developing innovative techniques and raising awareness about chronic diseases, further driving demand for blood testing. The rise in chronic disease prevalence, especially diabetes-expected to affect 783 million adults by 2031-will create substantial demand for health assessment products. Regulatory bodies like CMS and FDA are pivotal in promoting CLIA-compliant diagnostic tests that enhance early disease detection. This surge in regulatory support and rising health concerns offers lucrative opportunities for operational entities within the blood testing sector, positioning it for robust market expansion in the coming years.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Blood Testing market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Blood Testing Market Segmental Analysis

Global Blood Testing Market is segmented by type, methods, end user and region. Based on type, the market is segmented into glucose testing, lipid panel testing, prostate specific antigen (PSA) testing, blood urea nitrogen (BUN) testing, thyroid stimulating hormone testing and other types (Direct LDL Testing, Testosterone Testing). Based on methods, the market is segmented into manual blood testing and automated blood testing. Based on end user, the market is segmented into diagnostic laboratories, hospitals and other end users. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Blood Testing Market

The Global Blood Testing market is significantly influenced by several key drivers that contribute to its growth. One of the most crucial factors is the influx of external funding directed towards clinical studies focused on innovating advanced diagnostic technologies. Additionally, as patient awareness regarding various self-testing and home diagnostic options rises, this trend is expected to further boost the market. Moreover, the increasing prevalence of chronic diseases, coupled with a heightened demand for rapid health assessment products, suggests a strong upward trajectory for the global blood testing market in the upcoming years. These elements collectively create a favorable environment for market expansion.

Restraints in the Global Blood Testing Market

The Global Blood Testing market faces significant challenges that may impede its growth, particularly in developing nations like India, Indonesia, and Malaysia. A key restraint is the limited awareness among patients regarding advanced technological devices, which can inhibit adoption rates. Additionally, the high costs associated with these devices and self-testing kits are anticipated to further suppress market demand in the foreseeable future. These factors collectively contribute to a slower market advancement, highlighting the need for increased education and more affordable options to enhance accessibility and utilization of blood testing technologies in these regions.

Market Trends of the Global Blood Testing Market

The global blood testing market is witnessing significant growth driven by advancements in technology and a surge in demand for accurate diagnostic solutions. Key players are increasingly leveraging innovations, particularly Artificial Intelligence, to enhance the precision and speed of disease detection, enabling early intervention and improved patient outcomes. This focus on integrating cutting-edge technologies not only streamlines testing processes but also caters to the evolving needs of healthcare providers and patients alike. As a result, the market is poised for expansion, with a notable emphasis on developing user-friendly products that enhance accessibility and efficiency, thereby reshaping the landscape of blood diagnostics worldwide.

Table of Contents

Introduction

  • Objectives of the Study
  • Scope of the Report
  • Definitions

Research Methodology

  • Information Procurement
  • Secondary & Primary Data Methods
  • Market Size Estimation
  • Market Assumptions & Limitations

Executive Summary

  • Global Market Outlook
  • Supply & Demand Trend Analysis
  • Segmental Opportunity Analysis

Market Dynamics & Outlook

  • Market Overview
  • Market Size
  • Market Dynamics
    • Drivers & Opportunities
    • Restraints & Challenges
  • Porters Analysis
    • Competitive rivalry
    • Threat of substitute
    • Bargaining power of buyers
    • Threat of new entrants
    • Bargaining power of suppliers

Key Market Insights

  • Key Success Factors
  • Degree of Competition
  • Top Investment Pockets
  • Market Ecosystem
  • Market Attractiveness Index, 2023
  • PESTEL Analysis
  • Macro-Economic Indicators
  • Value Chain Analysis
  • Pricing Analysis
  • Technological Advancement
  • Regulatory Landscape
  • Case Studies
  • Patent Analysis

Global Blood Testing Market Size by Type & CAGR (2024-2031)

  • Market Overview
  • Glucose Testing
  • Lipid Panel Testing
  • Prostate Specific Antigen (PSA) Testing
  • Blood Urea Nitrogen (BUN) Testing
  • Thyroid Stimulating Hormone Testing
  • Other Types
    • Direct LDL Testing
    • Testosterone Testing

Global Blood Testing Market Size by Methods & CAGR (2024-2031)

  • Market Overview
  • Manual Blood Testing
  • Automated Blood Testing

Global Blood Testing Market Size by End User & CAGR (2024-2031)

  • Market Overview
  • Diagnostic Laboratories
  • Hospitals
  • Other End Users

Global Blood Testing Market Size & CAGR (2024-2031)

  • North America (Type, Methods, End User)
    • USA
    • Canada
  • Europe (Type, Methods, End User)
    • Germany
    • Spain
    • France
    • UK
    • Italy
    • Rest of Europe
  • Asia Pacific (Type, Methods, End User)
    • China
    • India
    • Japan
    • South Korea
    • Rest of Asia-Pacific
  • Latin America (Type, Methods, End User)
    • Brazil
    • Rest of Latin America
  • Middle East & Africa (Type, Methods, End User)
    • GCC Countries
    • South Africa
    • Rest of Middle East & Africa

Competitive Intelligence

  • Top 5 Player Comparison
  • Market Positioning of Key Players, 2023
  • Strategies Adopted by Key Market Players
  • Recent Developments in the Market
  • Company Market Share Analysis, 2023
  • Company Profiles of All Key Players
    • Company Details
    • Product Portfolio Analysis
    • Company's Segmental Share Analysis
    • Revenue Y-O-Y Comparison (2021-2023)

Key Company Profiles

  • Abbott
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • F. Hoffmann-La Roche Ltd
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Bio-Rad Laboratories, Inc.
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • bioMerieux
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Quest Diagnostics Incorporated
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Biomerica
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • BD
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Siemens Healthineers AG
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Danaher Corporation
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Trinity Biotech Plc
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Thermo Fisher Scientific
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Sysmex Corporation
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Dr Lal PathLabs Limited
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Alere Inc.
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Cepheid Corporation
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments

Conclusion & Recommendations